Survival after allogeneic bone marrow transplantation (BMT) in patients randomised into a trial of IFN-alpha versus chemotherapy: No significant adverse effect of prolonged IFN-alpha administration.

Slični predmeti

• INTERFERON-ALPHA(IFN-ALPHA) PROLONGS SURVIVAL FOR PATIENTS WITH CML IN CHRONIC PHASE - PRELIMINARY-RESULTS OF THE UK MRC RANDOMIZED MULTICENTER TRIAL
  od: Allan, N, i dr.
  Izdano: (1994)
• A role for the transcription factor RelB in IFN-alpha production and in IFN-alpha-stimulated cross-priming.
  od: Le Bon, A, i dr.
  Izdano: (2006)
• Intracellular production of IFN-alpha 2b in Lactococcus lactis
  od: Bayat, Omid, i dr.
  Izdano: (2014)
• Interferon alpha (IFN-α) in systemic lupus erythematosus (SLE)
  od: Sara Moqbil, i dr.
  Izdano: (2022-11-01)
• Pathways of IFN-alpha Activation in Patients with Cervical Intraepithelial Neoplasia (CIN)
  od: Nelson Ranieri Tirone, i dr.
  Izdano: (2021-11-01)